Pediatric cancer gene database (Pedican) Home
Pedican
Pediatric cancer database
General information | Literature | Expression | Regulation | Variant | Interaction

Basic Information

Gene ID

4846

Name

NOS3

Synonym

ECNOS|eNOS;nitric oxide synthase 3 (endothelial cell);NOS3;nitric oxide synthase 3 (endothelial cell)

Definition

EC-NOS|NOS type III|NOSIII|cNOS|constitutive NOS|endothelial NOS|nitric oxide synthase, endothelial

Position

7q36

Gene Type

protein-coding

Pathways and Diseases

Pathway

VEGFR1 specific signals;PID Curated;200151

Pathway

ion channels and their functional role in vascular endothelium;PID BioCarta;100055

Pathway

VEGF signaling pathway;KEGG PATHWAY;hsa04370

Pathway

Endothelin signaling pathway;PANTHER;P00019

Pathway

corticosteroids and cardioprotection;PID BioCarta;100156

Pathway

eNOS activation;PID Reactome;500849

Pathway

PI3 kinase pathway;PANTHER;P00048

Pathway

Metabolism of nitric oxide;Reactome;REACT:12508

Pathway

citrulline-nitric oxide cycle;BioCyc;PWY-4983

Pathway

Signaling events mediated by VEGFR1 and VEGFR2;PID Curated;200161

Pathway

VEGF signaling pathway;PANTHER;P00056

Pathway

Plasma membrane estrogen receptor signaling;PID Curated;200029

Pathway

Thromboxane A2 receptor signaling;PID Curated;200069

Pathway

hypoxia-inducible factor in the cardivascular system;PID BioCarta;100145

Pathway

Validated transcriptional targets of AP1 family members Fra1 and Fra2;PID Curated;200044

Pathway

Calcium signaling pathway;KEGG PATHWAY;hsa04020

Pathway

Angiogenesis;PANTHER;P00005

Pathway

actions of nitric oxide in the heart;PID BioCarta;100094

Pathway

Angiopoietin receptor Tie2-mediated signaling;PID Curated;200066

Pathway

superpathway of citrulline metabolism;BioCyc;PWY-5004

Pathway

Hemostasis;Reactome;REACT:604

Pathway

Arginine and proline metabolism;KEGG PATHWAY;hsa00330

Pathway

Metabolic pathways;KEGG PATHWAY;hsa01100

Pathway

vegf hypoxia and angiogenesis;PID BioCarta;100006

Pathway

Interleukin signaling pathway;PANTHER;P00036

Disease

cognitive impairment;GAD

Disease

thromboembolism, venous;GAD

Disease

Bacteremia;GAD

Disease

lead toxicity;GAD

Disease

Alzheimer disease, late-onset, susceptibility to;OMIM

Disease

arterial stiffness;GAD

Disease

Escherichia coli Infections;GAD

Disease

cardiac death;GAD

Disease

Subarachnoid Hemorrhage;GAD

Disease

DEVELOPMENTAL;GAD

Disease

congestive heart failure;GAD

Disease

endothelium-dependent arterial dilation;GAD

Disease

IMMUNE;GAD

Disease

endometriosis;GAD

Disease

atherosclerosis, carotid intima media thickness;GAD

Disease

vasodilation;GAD

Disease

kidney dysfunction;GAD

Disease

blood pressure;GAD

Disease

angina, vasospastic;GAD

Disease

PSYCH;GAD

Disease

heart disease, ischemic;GAD

Disease

cardiopulmonary disease;GAD

Disease

Placental abruption;OMIM

Disease

Angina, Unstable;GAD

Disease

vasospastic angina associated;GAD

Disease

Pulmonary Edema;GAD

Disease

coronary atherosclerotic heart disease in Chinese;GAD

Disease

nephropathy, diabetic;GAD

Disease

enhanced vascular responsiveness to phenylephrine;GAD

Disease

Fabry disease;GAD

Disease

coronary vasomotor function;GAD

Disease

carotid artery stenosis;GAD

Disease

blood flow;GAD

Disease

Hypotension;GAD

Disease

smoking;GAD

Disease

renal disease;GAD

Disease

metabolic syndrome;GAD

Disease

Hypertriglyceridemia;GAD

Disease

myocardial infarct;GAD

Disease

polycystic kidney disease;GAD

Disease

pregnancy loss, recurrent;GAD

Disease

Insulin Resistance;GAD

Disease

cardiovascular;GAD

Disease

sickle cell anemia;GAD

Disease

C-reactive protein;GAD

Disease

giant cell arteritis.;GAD

Disease

nephropathy;GAD

Disease

hypertension;GAD

Disease

stroke, ischemic;GAD

Disease

vulvar cancer;GAD

Disease

neural tube defects;GAD

Disease

atherosclerosis, coronary;GAD

Disease

sclerosis, systemic;GAD

Disease

kidney transplant;GAD

Disease

renal disease, end stage;GAD

Disease

high-altitude pulmonary edema.;GAD

Disease

cardiovascular disease;GAD

Disease

Ischemic stroke, susceptibility to;OMIM

Disease

prostate cancer;GAD

Disease

Vasculitis;GAD

Disease

cholesterol cholesterol, LDL fibrinogen lipoprotein myocardial infarct nitrate triglycerides;GAD

Disease

placental abruption;GAD

Disease

METABOLIC;GAD

Disease

brain aneurysm;GAD

Disease

Hypertension, susceptibility to;OMIM

Disease

diabetes, type 1;GAD

Disease

preeclampsia;GAD

Disease

systemic sclerosis;GAD

Disease

Kidney Failure, Chronic;GAD

Disease

homocysteine;GAD

Disease

NORMALVARIATION;GAD

Disease

hypertension, pregnancy induced;GAD

Disease

Atherosclerosis;GAD

Disease

Vasospasm, Intracranial;GAD

Disease

coronary spasm.;GAD

Disease

intracranial aneurysms;GAD

Disease

Behcet's Disease;GAD

Disease

tardive dyskinesia;GAD

Disease

suicide;GAD

Disease

elite athletes;GAD

Disease

chronic obstructive pulmonary disease/COPD;GAD

Disease

Myocardial Infarction;GAD

Disease

end stage renal disease;GAD

Disease

Hypertension, pregnancy-induced;OMIM

Disease

bipolar disorder;GAD

Disease

exhaled nitric oxide levels;GAD

Disease

blood pressure, arterial hypertension;GAD

Disease

hypertension, cirrhotic portal;GAD

Disease

heart period signal;GAD

Disease

Atrial Fibrillation;GAD

Disease

peripheral vascular disease;GAD

Disease

white blood cell count;GAD

Disease

HEMATOLOGICAL;GAD

Disease

erectile dysfunction;GAD

Disease

Pseudomonas aeruginosa infection;GAD

Disease

endothelial function von Willebrand factor;GAD

Disease

AGING;GAD

Disease

Acute Coronary Syndrome;GAD

Disease

neuropathy, non-arteritic ischaemic optic;GAD

Disease

Altitude Sickness;GAD

Disease

periodontal disease;GAD

Disease

sickle cell disease;GAD

Disease

fibrinogen;GAD

Disease

Behcet Syndrome;GAD

Disease

lupus erythematosus;GAD

Disease

high-altitude pulmonary edema;GAD

Disease

retinopathy, diabetic;GAD

Disease

colorectal cancer;GAD

Disease

Diabetic Retinopathy;GAD

Disease

diabetes, type 2;GAD

Disease

Coronary Artery Disease;GAD

Disease

Chronic renal failure;GAD

Disease

macular edema;GAD

Disease

CARDIOVASCULAR;GAD

Disease

insulin;GAD

Disease

cerebral circulation;GAD

Disease

coronary in-stent restenosis.;GAD

Disease

restenosis;GAD

Disease

INFECTION;GAD

Disease

REPRODUCTION;GAD

Disease

blood pressure, arterial;GAD

Disease

vasodilation during pregnancy;GAD

Disease

angina;GAD

Disease

pulmonary function;GAD

Disease

homocystinuria;GAD

Disease

breast cancer;GAD

Disease

coronary heart disease;GAD

Disease

ovarian cancer;GAD

Disease

migraine with aura;GAD

Disease

diabetic nephropathy;GAD

Disease

pulmonary hypertension;GAD

Disease

allergy asthma;GAD

Disease

preterm delivery;GAD

Disease

Alzheimer's disease;GAD

Disease

platelet aggregation;GAD

Disease

nitric oxide activity;GAD

Disease

carotid atherosclerosis;GAD

Disease

Essential Hypertension;GAD

Disease

Skin Diseases;GAD

Disease

end-stage renal disease;GAD

Disease

nephropathy in other diseases;GAD

Disease

Cerebral Circulation in Smokers;GAD

Disease

Gram-Positive Bacterial Infections;GAD

Disease

endothelial function;GAD

Disease

Osteomyelitis;GAD

Disease

Asthma;GAD

Disease

vessel stenosis;GAD

Disease

peritoneal transport;GAD

Disease

heart rate;GAD

Disease

hyperhomocystinemia;GAD

Disease

endurance performance;GAD

Disease

bone density fracture risk;GAD

Disease

CANCER;GAD

Disease

coronary vasculopathy;GAD

Disease

Stroke;GAD

Disease

carotid intima-media thickness;GAD

Disease

giant cell arteritis;GAD

Disease

NEUROLOGICAL;GAD

Disease

cholesterol, LDL;GAD

Disease

arterial disease;GAD

Disease

Coronary artery spasm 1, susceptibility to;OMIM

Disease

hypertension,response to exercise;GAD

Disease

nitric oxide;GAD

Disease

lung cancer;GAD

Disease

RENAL;GAD

External Links

Links to Entrez Gene

4846

Links to all GeneRIF Items

4846

Links to iHOP

4846

Sequence Information

Nucleotide Sequence

>4846 : length: 3612
atgggcaacttgaagagcgtggcccaggagcctgggccaccctgcggcctggggctgggg
ctgggccttgggctgtgcggcaagcagggcccagccaccccggcccctgagcccagccgg
gccccagcatccctactcccaccagcgccagaacacagccccccgagctccccgctaacc
cagcccccagaggggcccaagttccctcgtgtgaagaactgggaggtggggagcatcacc
tatgacaccctcagcgcccaggcgcagcaggatgggccctgcaccccaagacgctgcctg
ggctccctggtatttccacggaaactacagggccggccctcccccggccccccggcccct
gagcagctgctgagtcaggcccgggacttcatcaaccagtactacagctccattaagagg
agcggctcccaggcccacgaacagcggcttcaagaggtggaagccgaggtggcagccaca
ggcacctaccagcttagggagagcgagctggtgttcggggctaagcaggcctggcgcaac
gctccccgctgcgtgggccggatccagtgggggaagctgcaggtgttcgatgcccgggac
tgcaggtctgcacaggaaatgttcacctacatctgcaaccacatcaagtatgccaccaac
cggggcaaccttcgctcggccatcacagtgttcccgcagcgctgccctggccgaggagac
ttccgaatctggaacagccagctggtgcgctacgcgggctaccggcagcaggatggctct
gtgcggggggacccagccaacgtggagatcaccgagctctgcattcagcacggctggacc
ccaggaaacggtcgcttcgacgtgctgcccctgctgctgcaggccccagatgatccccca
gaactcttccttctgccccccgagctggtccttgaggtgcccctggagcaccccacgctg
gagtggtttgcagccctgggcctgcgctggtacgccctcccggcagtgtccaacatgctg
ctggaaattgggggcctggagttccccgcagcccccttcagtggctggtacatgagcact
gagatcggcacgaggaacctgtgtgaccctcaccgctacaacatcctggaggatgtggct
gtctgcatggacctggatacccggaccacctcgtccctgtggaaagacaaggcagcagtg
gaaatcaacgtggccgtgctgcacagttaccagctagccaaagtcaccatcgtggaccac
cacgccgccacggcctctttcatgaagcacctggagaatgagcagaaggccagggggggc
tgccctgcagactgggcctggatcgtgccccccatctcgggcagcctcactcctgttttc
catcaggagatggtcaactatttcctgtccccggccttccgctaccagccagacccctgg
aaggggagtgccgccaagggcaccggcatcaccaggaagaagacctttaaagaagtggcc
aacgccgtgaagatctccgcctcgctcatgggcacggtgatggcgaagcgagtgaaggcg
acaatcctgtatggctccgagaccggccgggcccagagctacgcacagcagctggggaga
ctcttccggaaggcttttgatccccgggtcctgtgtatggatgagtatgacgtggtgtcc
ctcgaacacgagacgctggtgctggtggtaaccagcacatttgggaatggggatcccccg
gagaatggagagagctttgcagctgccctgatggagatgtccggcccctacaacagctcc
cctcggccggaacagcacaagagttataagatccgcttcaacagcatctcctgctcagac
ccactggtgtcctcttggcggcggaagaggaaggagtccagtaacacagacagtgcaggg
gccctgggcaccctcaggttctgtgtgttcgggctcggctcccgggcatacccccacttc
tgcgcctttgctcgtgccgtggacacacggctggaggaactgggcggggagcggctgctg
cagctgggccagggcgacgagctgtgcggccaggaggaggccttccgaggctgggcccag
gctgccttccaggccgcctgtgagaccttctgtgtgggagaggatgccaaggccgccgcc
cgagacatcttcagccccaaacggagctggaagcgccagaggtaccggctgagcgcccag
gccgagggcctgcagttgctgccaggtctgatccacgtgcacaggcggaagatgttccag
gctacaatccgctcagtggaaaacctgcaaagcagcaagtccacgagggccaccatcctg
gtgcgcctggacaccggaggccaggaggggctgcagtaccagccgggggaccacataggt
gtctgcccgcccaaccggcccggccttgtggaggcgctgctgagccgcgtggaggacccg
ccggcgcccactgagcccgtggcagtagagcagctggagaagggcagccctggtggccct
ccccccggctgggtgcgggacccccggctgcccccgtgcacgctgcgccaggctctcacc
ttcttcctggacatcacctccccacccagccctcagctcttgcggctgctcagcaccttg
gcagaagagcccagggaacagcaggagctggaggccctcagccaggatccccgacgctac
gaggagtggaagtggttccgctgccccacgctgctggaggtgctggagcagttcccgtcg
gtggcgctgcctgccccactgctcctcacccagctgcctctgctccagccccggtactac
tcagtcagctcggcacccagcacccacccaggagagatccacctcactgtagctgtgctg
gcatacaggactcaggatgggctgggccccctgcactatggagtctgctccacgtggcta
agccagctcaagcccggagaccctgtgccctgcttcatccggggggctccctccttccgg
ctgccacccgatcccagcttgccctgcatcctggtgggtccaggcactggcattgccccc
ttccggggattctggcaggagcggctgcatgacattgagagcaaagggctgcagcccact
cccatgactttggtgttcggctgccgatgctcccaacttgaccatctctaccgcgacgag
gtgcagaacgcccagcagcgcggggtgtttggccgagtcctcaccgccttctcccgggaa
cctgacaaccccaagacctacgtgcaggacatcctgaggacggagctggctgcggaggtg
caccgcgtgctgtgcctcgagcggggccacatgtttgtctgcggcgatgttaccatggca
accaacgtcctgcagaccgtgcagcgcatcctggcgacggagggcgacatggagctggac
gaggccggcgacgtcatcggcgtgctgcgggatcagcaacgctaccacgaagacattttc
gggctcacgctgcgcacccaggaggtgacaagccgcatacgcacccagagcttttccttg
caggagcgtcagttgcggggcgcagtgccctgggcgttcgaccctcccggctcagacacc
aacagcccctga

Protein Sequence

>4846 : length: 1203
MGNLKSVAQEPGPPCGLGLGLGLGLCGKQGPATPAPEPSRAPASLLPPAPEHSPPSSPLT
QPPEGPKFPRVKNWEVGSITYDTLSAQAQQDGPCTPRRCLGSLVFPRKLQGRPSPGPPAP
EQLLSQARDFINQYYSSIKRSGSQAHEQRLQEVEAEVAATGTYQLRESELVFGAKQAWRN
APRCVGRIQWGKLQVFDARDCRSAQEMFTYICNHIKYATNRGNLRSAITVFPQRCPGRGD
FRIWNSQLVRYAGYRQQDGSVRGDPANVEITELCIQHGWTPGNGRFDVLPLLLQAPDDPP
ELFLLPPELVLEVPLEHPTLEWFAALGLRWYALPAVSNMLLEIGGLEFPAAPFSGWYMST
EIGTRNLCDPHRYNILEDVAVCMDLDTRTTSSLWKDKAAVEINVAVLHSYQLAKVTIVDH
HAATASFMKHLENEQKARGGCPADWAWIVPPISGSLTPVFHQEMVNYFLSPAFRYQPDPW
KGSAAKGTGITRKKTFKEVANAVKISASLMGTVMAKRVKATILYGSETGRAQSYAQQLGR
LFRKAFDPRVLCMDEYDVVSLEHETLVLVVTSTFGNGDPPENGESFAAALMEMSGPYNSS
PRPEQHKSYKIRFNSISCSDPLVSSWRRKRKESSNTDSAGALGTLRFCVFGLGSRAYPHF
CAFARAVDTRLEELGGERLLQLGQGDELCGQEEAFRGWAQAAFQAACETFCVGEDAKAAA
RDIFSPKRSWKRQRYRLSAQAEGLQLLPGLIHVHRRKMFQATIRSVENLQSSKSTRATIL
VRLDTGGQEGLQYQPGDHIGVCPPNRPGLVEALLSRVEDPPAPTEPVAVEQLEKGSPGGP
PPGWVRDPRLPPCTLRQALTFFLDITSPPSPQLLRLLSTLAEEPREQQELEALSQDPRRY
EEWKWFRCPTLLEVLEQFPSVALPAPLLLTQLPLLQPRYYSVSSAPSTHPGEIHLTVAVL
AYRTQDGLGPLHYGVCSTWLSQLKPGDPVPCFIRGAPSFRLPPDPSLPCILVGPGTGIAP
FRGFWQERLHDIESKGLQPTPMTLVFGCRCSQLDHLYRDEVQNAQQRGVFGRVLTAFSRE
PDNPKTYVQDILRTELAAEVHRVLCLERGHMFVCGDVTMATNVLQTVQRILATEGDMELD
EAGDVIGVLRDQQRYHEDIFGLTLRTQEVTSRIRTQSFSLQERQLRGAVPWAFDPPGSDT
NSP



')